Development of Severe Impairment Common in Long-Term Care Residents
By Lori Solomon HealthDay Reporter
THURSDAY, May 1, 2025 -- Development of severe permanent cognitive or functional impairment is common among residents admitted to long-term care (LTC), according to a study published online April 23 in JAMA Network Open.
Ramtin Hakimjavadi, M.D., from the University of Ottawa in Ontario, Canada, and colleagues assessed the incidence of severe cognitive and functional impairment among people admitted to LTC, as well as life expectancy after impairment. The analysis included administrative health data from 120,238 older adults admitted to LTC facilities between April 1, 2013, and March 31, 2018, and followed until death, discharge, or April 1, 2023.
The researchers found that during the study period, 20.0 percent of at-risk residents had become permanently unable to make decisions, 7.7 percent had become permanently unable to communicate, 13.4 percent developed total care dependence, and 32.8 percent developed incontinence of stool or urine. The shortest median survival time was seen for residents who entered a state of total care dependence (45 days), and the longest median survival was seen for those with newly developed incontinence of stool or urine (356 days). Longer median survival after entering a state of severe impairment was seen for younger residents (median survival after developing total care dependence: 133 days for those younger than 80 years versus 30 days for those aged 80 years and older) and those with dementia at admission (median survival after developing the inability to make decisions: 318 days with dementia versus 74 days without dementia).
"These results suggest that building shared understanding and open communication about the natural course of frailty trajectories for LTC residents may support resident-centered medical decision-making," the authors write.
One author disclosed being a cofounder of CANImmunize Inc.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
FRIDAY, July 11, 2025 -- For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild cognitive impairment (MCI)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.